Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06639607
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-07
Brief Title:
PEP-CMV Nivolumab for Newly Diagnosed Diffuse Midline GliomaHigh-grade Glioma and Recurrent Diffuse Midline GliomaHigh-grade Glioma Medulloblastoma and Ependymoma
Sponsor:
Organization:
None